Gynecologic Oncology Consult

Same-day discharge for hysterectomy


 

Dr. Rossi is an assistant professor in the division of gynecologic oncology at the University of North Carolina at Chapel Hill.

References

1. Fountain CR et al. Promoting same-day discharge for gynecologic oncology patients in minimally invasive hysterectomy. J Minim Invasive Gynecol. 2017 Sep-Oct;24(6):932-9.

2. Rivard C et al. Factors influencing same-day hospital discharge and risk factors for readmission after robotic surgery in the gynecologic oncology patient population. J Minim Invasive Gynecol. 2015 Feb;22(2):219-26.

3. Lee SJ et al. The feasibility and safety of same-day discharge after robotic-assisted hysterectomy alone or with other procedures for benign and malignant indications. Gynecol Oncol. 2014 Jun;133(3):552-5.

4. Elia N et al. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology. 2005 Dec;103(6):1296-304.

5. Donnez O et al. Low pain score after total laparoscopic hysterectomy and same-day discharge within less than 5 hours: Results of a prospective observational study. J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1293-9.

Pages

Recommended Reading

Approach to the asymptomatic adnexal mass: When to operate, refer, or observe
MDedge ObGyn
New multi-analyte blood test shows promise in screening for several common solid tumors
MDedge ObGyn
Letrozole promising as maintenance treatment for high-grade serous ovarian cancer
MDedge ObGyn
USPSTF: Routine screens for ovarian cancer not recommended
MDedge ObGyn
FDA approves new HPV assay
MDedge ObGyn
Telling her she has cancer: A patient-centered approach to breaking bad news
MDedge ObGyn
2018 Update on gynecologic cancer
MDedge ObGyn
Avelumab safety compares with other checkpoint inhibitors
MDedge ObGyn
FDA authorizes first direct-to-consumer BRCA1/2 test
MDedge ObGyn
Chlamydia infections associated with more than a doubling of ovarian cancer risk
MDedge ObGyn